New biosensor could save lives by giving faster medical analysis
Every day accident and emergency units have to treat patients who have taken some sort of drug overdose. To give treatment doctors need to know what the patient has taken. The circumstances can make often this difficult to ascertain quickly.
Researchers are developing a new kind of biosensor, which can determine in minutes if a patient’s blood contains a particular compound, for example paracetamol. Currently this type of examination needs to be carried out in a laboratory, which is expensive and time consuming.
The research is being carried out by Dr Sub Reddy’s team at the University of Surrey with funding from the Swindon based Engineering and Physical Sciences Research Council.
The sensor system can return a response in less than 10 minutes compared to the 2 – 3 hours required by a routine laboratory, depending on their workload. “Our sensor is portable and will be easy to use even by unskilled staff,” says Dr. Reddy. “Ideally, the overdose sensor may be located in the ambulance so that a result is available when the patient arrives at hospital.” The paracetamol sensor is the pilot to the development of an array of overdose sensors, which will test for alcohol and anti-depressants as well.
The capabilities of the biosensor extend far beyond helping patients who have taken a drug overdose. “We have successfully used the system to detect glucose,” says Dr Reddy. The team is also investigating the detection of creatinine, a product in the body, which is an indicator of kidney dysfunction.
The heart of the biosensor consists of a disc-shaped quartz crystal, around a centimetre in diameter and 0.2 mm thick. “When an alternating electric field is applied the crystal vibrates from side to side, like a nano-scale earthquake,” says Dr Reddy. “It shakes ten million times a second with an amplitude of a fraction of a nanometre.” The crystal can continue to oscillate even when immersed in a liquid. Anything which then sticks to the crystal surface or which affects the viscosity or elasticity of any attached film at the surface will affect the frequency at which the crystal vibrates.
The concept of the sensor is to have a small reaction chamber above the surface of the crystal. When a sample – blood, say – is placed in the chamber a series of carefully designed chemical reactions can be made to occur which result in the molecule of interest – for example cholesterol – contributing to the formation of a solid product. The product then attaches to the surface of the crystal, affecting the frequency of its oscillation.
Because the chemical reaction can be made to be highly specific to the molecule of interest so that only one solid product is formed, other substances in the sample will not interfere with the process or provide spurious readings.
Dr. Reddy explained how the biosensor has been used to detect glucose. “Here you add the sample to the reaction mixture. An enzyme oxidises the glucose to form hydrogen peroxide. This in turn is acted upon by a second enzyme and reacts with other ingredients in the mixture to form a water repelling molecule, which comes out of solution and can be made to attach to the quartz. This causes a change in the oscillation frequency which can be correlated with the quantity of product, which can in turn be related to the amount of glucose originally present in the sample.”
Dr Reddy believes that his team has demonstrated the feasibility of the concept of using a quartz crystal sensor in this way. “We have shown that the system has excellent sensitivity. We are getting extremely large signals.”
The researchers are now looking into ways of refining the system, by using membranes above the surface, which are selective for specific types of molecule, for example. This would ‘filter out’ any potentially contaminating species to provide a much cleaner and unambiguous reading. “We are building up a portfolio of detection strategies for compounds of interest and we are now reaching the stage where we are looking for industrial collaborators. We are also applying this viscoelastic sensor to lab-on-a-chip type technologies, as well as integrating it with synthetic polymer films capable of molecular recognition,” says Dr Reddy.
Jane Reck | alfa
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
Northwestern discovery tool is thousands of times faster than conventional screening methods
Different eras of civilization are defined by the discovery of new materials, as new materials drive new capabilities. And yet, identifying the best material...
Researchers from the University of Basel have reported a new method that allows the physical state of just a few atoms or molecules within a network to be controlled. It is based on the spontaneous self-organization of molecules into extensive networks with pores about one nanometer in size. In the journal ‘small’, the physicists reported on their investigations, which could be of particular importance for the development of new storage devices.
Around the world, researchers are attempting to shrink data storage devices to achieve as large a storage capacity in as small a space as possible. In almost...
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
Personal patches could reduce energy waste in buildings, Rutgers-led study says
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...